iBio (IBIO) Net Margin Growth (1y) (2012 - 2025)
iBio (IBIO) Net Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4,168.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 673.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,208.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -1,652.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,636.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -392.00 |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 17,071.00 |
| Mar 31, 2022 | 32,147.00 |
| Sep 30, 2021 | -440,135.00 |
| Jun 30, 2021 | 33,208.00 |
| Mar 31, 2021 | 392,874.00 |
| Dec 31, 2020 | 692,276.00 |
| Sep 30, 2020 | 234,010.00 |
| Jun 30, 2020 | 25,289.00 |
| Mar 31, 2020 | -412,507.00 |
| Dec 31, 2019 | -738,856.00 |
| Sep 30, 2019 | 572,648.00 |
| Jun 30, 2019 | 435,178.00 |
| Mar 31, 2019 | 434,807.00 |
| Dec 31, 2018 | 189,438.00 |
| Sep 30, 2018 | -672,984.00 |
| Jun 30, 2018 | -193,794.00 |
| Mar 31, 2018 | 548,441.00 |
| Dec 31, 2017 | 171,448.00 |
| Sep 30, 2017 | -92,276.00 |
| Jun 30, 2017 | -201,498.00 |